CLINICAL_TRIALS trial_result · 2018-10-04

Clinical Trial Update: MTX Discontinuation and Vaccine Response [Phase 4]

Phase 4 trial update on MTX discontinuation and vaccine response in rheumatoid arthritis patients; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Seoul National University Hospital | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2018-10-04